Arrayus’ Focused Ultrasound Therapy System Approved in Canada

Health Canada has granted approval to Arrayus Technologies Inc.’s MRI-guided focused ultrasound system for uterine fibroid tissue ablation, a common gynecological condition.
 
Arrayus’ focused ultrasound system offers a transformative approach to non-invasive therapy, using high-precision acoustic energy to target and treat tissue deep within the body without the need for incisions or general anesthesia. Built with the world’s first clinically-available fully phased array, intuitive treatment planning tools and real-time therapy monitoring, the system enables clinicians to tailor treatments based on individual disease characteristics, ensuring precision while protecting nearby healthy tissue, according to the company.
 
“I am proud of our team for achieving this first milestone” Arrayus CEO James O’Reilly saod. “Securing Health Canada approval marks a pivotal moment in the evolution of our technology but it’s only the beginning. Our platform has the potential to transform patient care across multiple medical specialties. We are committed to pushing the boundaries of medical innovation to reduce the burden on the healthcare system and improve patient outcomes worldwide.”
 
Arrayus is actively expanding the potential applications for its focused ultrasound platform. The company has clinical trials underway to evaluate the use of its system in various oncological settings, and is working with healthcare professionals, researchers, and industry partners to explore its use in neurology, women’s health, and other areas. 

Arrayus Technologies Inc. is a privately-held medical device company that develops, manufactures, and commercializes focused ultrasound technology for oncology. Originally spun-out of Sunnybrook Research Institute, a global center of excellence in focused ultrasound, the company’s proprietary focused ultrasound technology combines a unique flat phased array design with advanced imaging and therapy monitoring for unprecedented treatment control and flexibility. This non-invasive technology can be used as an alternative or complement to traditional surgery, radiation therapy or immunotherapy. Arrayus has offices in Burlington and Toronto, Canada.